Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Primary Care Companion for CNS Disorders|September 6, 2023
Investigating Real-World Benztropine Usage Patterns in Movement Disorders: Claims Analysis and Health Care Provider Survey ResultsCraig Chepke, Betsy Benning, Samantha Cicero, et al.
Postgraduate Medicine|March 7, 2022
Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorderCraig Chepke, Rakesh Jain, Russell Rosenberg, et al.
BMC Psychiatry|January 11, 2022
The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approachChristoph U Correll, Craig Chepke, Paul Gionfriddo, et al.
BMJ Neurology Open|December 10, 2025
Patient and physician perceptions of the burden of tardive dyskinesia: an international surveyCraig Chepke, Aviva Peyser Levin, Amy Yang, et al.
The Mental Health Clinician|December 22, 2023
Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart reviewJonathan M Meyer, Craig Chepke, Rimal B Bera, et al.
Clinical Pharmacology in Drug Development|August 22, 2025
Exposure-Response Analysis for Aripiprazole Once-Monthly in Patients Diagnosed With Bipolar I DisorderXiaofeng Wang, Luann Phillips, Matthew Harlin, et al.
Neuropsychiatric Disease and Treatment|June 14, 2023
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect ComparisonMatthew Harlin, Craig Chepke, Frank Larsen, et al.
Pageof 2